tiprankstipranks
Eton Pharmaceuticals Inc (ETON)
NASDAQ:ETON
US Market
ETON
Eton Pharmaceuticals
RESEARCH TOOLSreports

Eton Pharmaceuticals (ETON) Income Statement

546 Followers

Eton Pharmaceuticals Income Statement

Last quarter (Q4 2025), Eton Pharmaceuticals's total revenue was $21.28M, an increase of 82.72% from the same quarter last year. In Q4, Eton Pharmaceuticals's net income was $1.48M. See Eton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 79.95M$ 39.01M$ 31.64M$ 21.25M$ 21.83M
Gross Profit
$ 42.74M$ 23.41M$ 21.06M$ 14.32M$ 19.21M
Operating Expenses
$ 42.67M$ 26.01M$ 22.25M$ 22.58M$ 20.70M
Depreciation and Amortization
$ 4.04M$ 1.15M$ 901.00K$ 1.77M$ 462.00K
EBITDA
$ 4.12M$ -1.45M$ -291.00K$ -6.49M$ -1.03M
Operating Income
$ 72.00K$ -2.60M$ -1.19M$ -8.26M$ -1.50M
Other Income/Expenses
$ -4.63M$ -1.21M$ 503.00K$ -761.00K$ -460.00K
Pretax Income
$ -4.56M$ -3.81M$ -689.00K$ -9.02M$ -1.96M
Net Income
$ -4.60M$ -3.82M$ -936.00K$ -9.02M$ -1.96M
Per Share Metrics
Basic EPS
$ -0.17$ -0.15$ -0.04$ -0.36$ -0.08
Diluted EPS
$ -0.17$ -0.15$ -0.04$ -0.36$ -0.08
Weighted Average Shares Outstanding
 26.91M 25.89M 25.64M 25.15M 25.21M
Weighted Average Shares Outstanding (Diluted)
 26.91M 25.89M 25.65M 25.15M 25.21M
Currency in USD

Eton Pharmaceuticals Earnings and Revenue History